Preparation method of bio-based wet adhesion hydrogel
By grafting cholesterol and dopamine in the hydrogel and combining dihydroxybenzene boron groups to form a self-crosslinked bio-based wet adhesion hydrogel, the poor adhesion performance of existing hydrogels in wet environments is solved. and swelling problems achieve stable adhesion and swelling resistance, avoid the use of chemical crosslinking agents, and ensure biocompatibility.
Patent Information
- Application Number
- CN202411416654.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-10-11
- Publication Date
- 2024-12-06
AI Technical Summary
Existing hydrogels have poor adhesion performance in wet environments and are prone to swelling, resulting in adhesion failure. Commonly used preparation methods require additional chemical crosslinking agents or ultraviolet light, which may cause secondary infection of the wound.
Through the acid chloride reaction and amide reaction, cholesterol chloroformate and dopamine are grafted onto polyethyleneimine and anionic polysaccharides, combining dihydroxybenzene boron groups to form a self-crosslinked bio-based wet adhesion hydrogel, using Imitation of mussels and hydrophobic strategies to achieve initial drainage and adhesion.
It achieves stable adhesion in humid environments, has excellent wet adhesion, swelling resistance and self-healing properties, no additional chemical crosslinking agent is required, and has good biocompatibility.
Smart Images

Figure CN119081158A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biomedical materials, and in particular relates to a method for preparing a bio-based wet adhesion hydrogel. Background Art
[0002] Hydrogel is a flexible material with a hydrophilic three-dimensional network and rich water components. Due to its high water content and compatibility with the human body structure, it has attracted extensive research by researchers. At present, hydrogels are widely used in biomedical fields such as soft robots, wearable devices, and tissue engineering. However, the moisture on the surface of wet tissue will form a barrier between the hydrogel and the tissue interface, weaken the interaction between the adhesive group and the tissue, and reduce the wet adhesion performance of the hydrogel. In addition, excessive water absorption will cause the hydrogel to swell, resulting in adhesion failure, thereby limiting its application. Currently, most of the methods commonly used to prepare hydrogels with anti-swelling / wet adhesion properties use free radical polymerization, which requires the additional introduction of ultraviolet light (CN202410359069.7) or chemical crosslinkers (CN202210636194.9), which may cause secondary infection of the wound. Therefore, it is of great clinical significance to develop a bio-based hydrogel with mild gelation conditions, anti-swelling, stable adhesion in a humid environment, and good biocompatibility. Summary of the invention
[0003] In order to overcome the defects of the above-mentioned technologies, the present invention provides a method for preparing a bio-based wet adhesion hydrogel.
[0004] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0005] Step 1: Cholesterol chloroformate is grafted onto the main chain of polyethyleneimine through an acyl chloride reaction to obtain an amphiphilic polymer cholesterol polyethyleneimine; the amphiphilic polymer is added to an alkaline solution to prepare an amphiphilic micelle dispersion.
[0006] Step 2: Graft dopamine onto the main chain of anionic polysaccharide through amide reaction to obtain dopamine-modified anionic polysaccharide; add the dopamine-modified anionic polysaccharide into an alkaline solution, heat and dissolve it to obtain solution A.
[0007] Step 3: Grafting the dihydroxyphenylborane group onto the main chain of the cationic polymer through an amide reaction to obtain a dihydroxyphenylborane-modified cationic polymer; adding the dihydroxyphenylborane-modified cationic polymer to the amphiphilic micelle dispersion prepared in step 1, heating and dissolving, and obtaining solution B.
[0008] Step 4: Mix the solution A in step 2 and the solution B in step 3, stir them thoroughly, and then cross-link them to obtain a bio-based wet adhesion hydrogel.
[0009] Further, in step 1, the concentration of the amphiphilic micelle dispersion is 0-15 mg / mL, and the alkaline solution is a solution with a pH>7. Preferably, the concentration of the amphiphilic micelle dispersion is 7.5 mg / mL; more preferably, the alkaline solution is a tris-hydrochloride buffer (Tris-HCl buffer), the concentration of the buffer is 50 mM, and the pH is 8.5.
[0010] Furthermore, in step 2, the anionic polysaccharide is selected from any one of the following: hyaluronic acid, sodium alginate, fucoidan, gellan gum, heparin, and chondroitin sulfate. Preferably, the anionic polysaccharide is hyaluronic acid.
[0011] Furthermore, in step 2, the content of dopamine-modified anionic polysaccharide in solution A is 2-10 wt.%. Preferably, the content of dopamine-modified anionic polysaccharide in solution A is 8 wt.%. More preferably, the alkaline solution is Tris-HCl buffer, the concentration of the buffer is 50 mM, and pH=8.5.
[0012] Furthermore, in step 2, the heating temperature is 30-60° C., and the heating time is 1-3 hours. Preferably, the heating temperature is 50° C.; more preferably, the heating time is 2 hours.
[0013] Further, in step 3, the cationic polymer is selected from any one of the following: ε-polylysine hydrochloride, chitosan oligosaccharide; the substance containing dihydroxyphenylboryl is selected from any one of the following: 4-carboxyphenylboronic acid, 3-carboxy-4-fluorophenylboronic acid. Preferably, the cationic polymer is ε-polylysine hydrochloride; more preferably, the substance containing dihydroxyphenylboronic acid is 4-carboxyphenylboronic acid.
[0014] Furthermore, in step 3, the content of the dihydroxyphenylboryl-modified cationic polymer in solution B is 20-50 wt. %. Preferably, the content of the dihydroxyphenylboryl-modified cationic polymer in solution B is 40 wt. %.
[0015] Furthermore, in step 3, the heating temperature is 30-60° C., and the heating time is 1-3 hours. Preferably, the heating temperature is 50° C.; more preferably, the heating time is 2 hours.
[0016] Furthermore, in step 4, the stirring time is 0.5 to 3 minutes. Preferably, the stirring time is 1 minute.
[0017] Compared with the prior art, the present invention has the following advantages and beneficial effects:
[0018] (1) Different from free radical polymerization, the hydrogel prepared by the present invention does not require the addition of additional chemical crosslinking agents or ultraviolet light initiation, and the gelation conditions are mild, which is a self-crosslinking hydrogel.
[0019] (2) The wet adhesion strategy used in the present invention is a mussel-mimicking strategy and a hydrophobic strategy, which uses the self-hydrophobic effect of the hydrogel to exert an initial drainage effect and gradually expose the adhesive groups to achieve stable adhesion to wet tissues.
[0020] (3) The hydrogel prepared by the present invention has excellent wet adhesion properties and can achieve good adhesion to wet tissues.
[0021] (4) The multiple cross-linked networks inside the hydrogel prepared by the present invention endow the hydrogel with good anti-swelling properties (swelling rate <150%).
[0022] (5) The wet adhesion hydrogel prepared by the present invention has excellent self-healing properties, can adjust the shape according to the size of the wound, is easy to use, and has a wide range of applications. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] Figure 1 The lap-shear adhesion strength of the hydrogel prepared in the present invention to pork tissue underwater.
[0024] Figure 2 Actual photos of the hydrogel prepared in the present invention adhered to the surfaces of different wet tissues (heart, lung, spleen and kidney).
[0025] Figure 3 The figure is a comparison chart of the swelling ratio of the hydrogel prepared by the present invention and the hydrogel prepared by free radical polymerization.
[0026] Figure 4 The rheological properties of the hydrogel prepared in the present invention. DETAILED DESCRIPTION
[0027] The present invention is further described in detail below with reference to the accompanying drawings and specific embodiments.
[0028] The bio-based wet adhesion hydrogel preparation method of the present invention, based on biomimetic mussel adhesion strategy and hydrophobic strategy, with natural polysaccharide and polylysine as the main body, by amide reaction, introduce catechol adhesive group, phenyl borate group, the two by electrostatic interaction and phenyl borate bond cross-linking to form hydrogel, no need to add chemical cross-linking agent to form gel. In addition, amphiphilic micelles are introduced by amide bonds to achieve the preparation of self-hydrophobic hydrogel. When the hydrogel is applied to a humid environment, under the induction of external water and internal electrostatic interaction, hydrophilic and hydrophobic chains are rearranged, and drainage is played, and adhesive groups (catechol groups, carboxyl groups, amino groups) are gradually exposed afterwards, and the strong adhesion to wet tissue is achieved. Therefore, the hydrogel prepared by the present invention shows strong wet adhesion, anti-swelling, self-healing, good biocompatibility and easy to use advantages.
[0029] Embodiment 1:
[0030] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0031] (1) Preparation of amphiphilic polymer cholesterol polyethyleneimine (PC): 1.85 g of branched polyethyleneimine was dissolved in 20 mL of DCM, stirred evenly in an ice bath, and after fully dissolved, 186 μL of TEA was added thereto. Then, 0.2 g of cholesterol chloroformate was dissolved in 5 mL of DCM and added dropwise to the mixture, and reacted in an ice bath at 0°C for 12 h. After the reaction was completed, DCM was removed by vacuum distillation at 33°C. The remaining product was transferred to a beaker, and ether was added thereto to wash away excess DCM, Chol and TEA. After drying, a PC sample was obtained and stored at -20°C.
[0032] Preparation of amphiphilic micelle dispersion: PC raw material was added into Tris-HCl buffer (50 mM, pH = 8.5) at a concentration of 7.5 mg / mL.
[0033] (2) Preparation of dopamine-modified hyaluronic acid (HD): At 25°C and nitrogen, 1 g of hyaluronic acid was dissolved in 100 mL of MES buffer (50 mM, pH = 5.5). The MES buffer was prepared by dissolving MES in deionized water, and the pH was adjusted to 5.5 using 5 M sodium hydroxide. After dissolution, 500 mg of EDC and 350 mg of NHS were added thereto, and the reaction was carried out for 30 min to activate the carboxyl group. Thereafter, 500 mg of dopamine was added under light-proof conditions, and the reaction was carried out for 24 h, during which the pH was maintained at 5 to 6. The HD sample was dialyzed using deionized water at pH = 5 (molecular weight cutoff of 3500 Da) for 3 days, the water was changed 3 times a day, and the HD sample was obtained by freeze-drying. The deionized water at pH = 5 was obtained by adjusting the pH using MES.
[0034] Preparation of solution A: The freeze-dried HD raw material was added into Tris-HCl buffer (50 mM, pH=8.5) at a ratio of 8 wt.%, and heated at 50° C. for 2 h to dissolve, thereby obtaining solution A.
[0035] (3) Preparation of 4-carboxyphenylboronic acid modified ε-polylysine hydrochloride (EP): 777 mg of 4-carboxyphenylboronic acid was dissolved in 130 mL of DM solvent (V (DMSO:MES) =1:1). After it is dissolved, 897 mg EDC and 539 mg NHS are added thereto, and the reaction is carried out for 30 min to activate the carboxyl group. Then, 1 g ε-polylysine hydrochloride is added thereto, and the pH value of the solution is maintained at 5-6. The reaction is carried out for 24 h. The EP sample is dialyzed with deionized water (molecular weight cut-off is 1000 Da) for 3 days, the water is changed 3 times a day, and the EP sample is obtained by freeze drying.
[0036] Preparation of solution B: Add the freeze-dried EP raw material at a ratio of 40 wt.% to the amphiphilic micelle dispersion prepared in step (1), heat and dissolve at 50°C for 2 h to obtain solution B.
[0037] (4) Preparation of bio-based wet adhesion hydrogel: Solution A in step (2) and solution B in step (3) were fully stirred for 1 min and then cross-linked to obtain HE7.5C hydrogel.
[0038] Embodiment 2:
[0039] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0040] (1) Preparation of amphiphilic polymer cholesterol polyethyleneimine (PC): 1.85 g of branched polyethyleneimine was dissolved in 20 mL of DCM, stirred evenly in an ice bath, and after fully dissolved, 186 μL of TEA was added thereto. Then, 0.2 g of cholesterol chloroformate was dissolved in 5 mL of DCM and added dropwise to the mixture, and reacted in an ice bath at 0°C for 12 h. After the reaction was completed, DCM was removed by vacuum distillation at 33°C. The remaining product was transferred to a beaker, and ether was added thereto to wash away excess DCM, Chol and TEA. After drying, a PC sample was obtained and stored at -20°C.
[0041] Preparation of amphiphilic micelle dispersion: PC raw material was added into NaOH solution (50 mM, pH = 8.5) at a concentration of 5 mg / mL.
[0042] (2) Preparation of dopamine-modified sodium alginate (AD): At 25°C and nitrogen, 1 g of sodium alginate was dissolved in 100 mL of MES buffer (50 mM, pH = 5.5). The MES buffer was prepared by dissolving MES in deionized water, and the pH was adjusted to 5.5 using 5 M sodium hydroxide. After dissolution, 500 mg of EDC and 350 mg of NHS were added thereto, and the reaction was allowed to proceed for 30 min to activate the carboxyl groups. Thereafter, 500 mg of dopamine was added under light-proof conditions, and the reaction was allowed to proceed for 24 h, during which the pH was maintained at 5 to 6. The sample was dialyzed with deionized water at pH = 5 (molecular weight cutoff of 3500 Da) for 3 days, the water was changed 3 times a day, and the AD sample was obtained by freeze-drying. The deionized water at pH = 5 was obtained by adjusting the pH using MES.
[0043] Preparation of solution A: Add the freeze-dried AD raw material into a NaOH solution (50 mM, pH=8.5) at a ratio of 2 wt.%, heat and dissolve at 35°C for 1 h to obtain solution A.
[0044] (3) Preparation of 4-carboxyphenylboronic acid modified ε-polylysine hydrochloride (EP): 777 mg of 4-carboxyphenylboronic acid was dissolved in 130 mL of DM solvent (V (DMSO:MES) =1:1). After it is dissolved, 897 mg EDC and 539 mg NHS are added thereto, and the reaction is carried out for 30 min to activate the carboxyl group. Then, 1 g ε-polylysine hydrochloride is added thereto, and the pH value of the solution is maintained at 5-6. The reaction is carried out for 24 h. The EP sample is dialyzed with deionized water (molecular weight cut-off is 1000 Da) for 3 days, the water is changed 3 times a day, and the EP sample is obtained by freeze drying.
[0045] Preparation of solution B: Add the freeze-dried EP raw material at a ratio of 30 wt.% to the amphiphilic micelle dispersion prepared in step (1), heat and dissolve at 35°C for 1 h to obtain solution B.
[0046] (4) Preparation of bio-based wet adhesion hydrogel: Solution A in step (2) and solution B in step (3) were fully stirred for 2 min and then cross-linked to obtain AE5C hydrogel.
[0047] Embodiment 3:
[0048] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0049] (1) Preparation of amphiphilic polymer cholesterol polyethyleneimine (PC): 1.85 g of branched polyethyleneimine was dissolved in 20 mL of DCM, stirred evenly in an ice bath, and after fully dissolved, 186 μL of TEA was added thereto. Then, 0.2 g of cholesterol chloroformate was dissolved in 5 mL of DCM and added dropwise to the mixture, and reacted in an ice bath at 0°C for 12 h. After the reaction was completed, DCM was removed by vacuum distillation at 33°C. The remaining product was transferred to a beaker, and ether was added thereto to wash away excess DCM, Chol and TEA. After drying, a PC sample was obtained and stored at -20°C.
[0050] Preparation of amphiphilic micelle dispersion: PC raw material was added into NaOH solution (50 mM, pH = 8.5) at a concentration of 10 mg / mL.
[0051] (2) Preparation of dopamine-modified fucoidan (FD): At 25°C and nitrogen, 1 g of fucoidan was dissolved in 100 mL of MES buffer (50 mM, pH = 5.5). The MES buffer was prepared by dissolving MES in deionized water, and the pH was adjusted to 5.5 using 5 M sodium hydroxide. After dissolution, 500 mg of EDC and 350 mg of NHS were added thereto, and the reaction was carried out for 30 min to activate the carboxyl group. Thereafter, 500 mg of dopamine was added under light-proof conditions, and the reaction was carried out for 24 h, during which the pH was maintained at 5-6. The FD sample was dialyzed with deionized water at pH = 5 (molecular weight cut-off of 3500 Da) for 3 days, the water was changed 3 times a day, and freeze-dried. The deionized water at pH = 5 was obtained by adjusting the pH using MES.
[0052] Preparation of solution A: The freeze-dried FD raw material was added into a NaOH solution (50 mM, pH=8.5) at a ratio of 2 wt.%, and heated to dissolve at 60°C for 2 h to obtain solution A.
[0053] (3) Preparation of 4-carboxyphenylboronic acid modified chitosan oligosaccharide (CP): 777 mg of 4-carboxyphenylboronic acid was dissolved in 130 mL of DM solvent (V (DMSO:MES) =1:1). After it is dissolved, 897 mg EDC and 539 mg NHS are added thereto, and the reaction is carried out for 30 min to activate the carboxyl group. Then, 1 g chitosan oligosaccharide is added thereto, and the pH value of the solution is maintained at 5-6. The reaction is carried out for 24 h. The CP sample is dialyzed with deionized water (molecular weight cut-off is 1000 Da) for 3 days, the water is changed 3 times a day, and the CP sample is obtained by freeze drying.
[0054] Preparation of solution B: Add the freeze-dried CP raw material at a ratio of 30 wt.% to the amphiphilic micelle dispersion prepared in step (1), heat and dissolve at 60°C for 2 h to obtain solution B.
[0055] (4) Preparation of bio-based wet adhesion hydrogel: Solution A in step (2) and solution B in step (3) were fully stirred for 3 minutes and then cross-linked to obtain FC10C hydrogel.
[0056] Embodiment 4:
[0057] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0058] (1) Preparation of amphiphilic polymer cholesterol polyethyleneimine (PC): 1.85 g of branched polyethyleneimine was dissolved in 20 mL of DCM, stirred evenly in an ice bath, and after fully dissolved, 186 μL of TEA was added thereto. Then, 0.2 g of cholesterol chloroformate was dissolved in 5 mL of DCM and added dropwise to the mixture, and reacted in an ice bath at 0°C for 12 h. After the reaction was completed, DCM was removed by vacuum distillation at 33°C. The remaining product was transferred to a beaker, and ether was added thereto to wash away excess DCM, Chol and TEA. After drying, a PC sample was obtained and stored at -20°C.
[0059] Preparation of amphiphilic micelle dispersion: PC raw material was added into NaOH solution (50 mM, pH = 8.5) at a concentration of 2.5 mg / mL.
[0060] (2) Preparation of dopamine-modified gellan gum (GD): At 25°C and nitrogen, 1 g of gellan gum was dissolved in 100 mL of MES buffer (50 mM, pH = 5.5). The MES buffer was prepared by dissolving MES in deionized water, and the pH was adjusted to 5.5 using 5 M sodium hydroxide. After dissolution, 500 mg of EDC and 350 mg of NHS were added thereto, and the mixture was reacted for 30 min to activate the carboxyl group. Thereafter, 500 mg of dopamine was added under light-proof conditions, and the mixture was reacted for 24 h, during which the pH was maintained at 5 to 6. The GD sample was dialyzed with deionized water at pH = 5 (molecular weight cut-off of 3500 Da) for 3 days, the water was changed 3 times a day, and the water was freeze-dried to obtain the GD sample. The deionized water at pH = 5 was obtained by adjusting the pH using MES.
[0061] Preparation of solution A: Add the freeze-dried GD raw material into a NaOH solution (50 mM, pH = 8.5) at a ratio of 2 wt.%, heat and dissolve at 40°C for 1 h to obtain solution A.
[0062] (3) Preparation of 4-carboxyphenylboronic acid modified chitosan oligosaccharide (CP): 777 mg of 4-carboxyphenylboronic acid was dissolved in 130 mL of DM solvent (V (DMSO:MES) =1:1). After it is dissolved, 897 mg EDC and 539 mg NHS are added thereto, and the reaction is carried out for 30 min to activate the carboxyl group. Then, 1 g chitosan oligosaccharide is added thereto, and the pH value of the solution is maintained at 5-6. The reaction is carried out for 24 h. The CP sample is dialyzed with deionized water (molecular weight cut-off is 1000 Da) for 3 days, the water is changed 3 times a day, and the CP sample is obtained by freeze drying.
[0063] Preparation of solution B: Add the freeze-dried CP raw material at a ratio of 30 wt.% to the amphiphilic micelle dispersion prepared in step (1), heat and dissolve at 40°C for 1 h to obtain solution B.
[0064] (4) Preparation of bio-based wet adhesion hydrogel: Solution A in step (2) and solution B in step (3) were fully stirred for 2 minutes and then cross-linked to obtain GC2.5C hydrogel.
[0065] Embodiment 5:
[0066] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0067] (1) Preparation of amphiphilic polymer cholesterol polyethyleneimine (PC): 1.85 g of branched polyethyleneimine was dissolved in 20 mL of DCM, stirred evenly in an ice bath, and after fully dissolved, 186 μL of TEA was added thereto. Then, 0.2 g of cholesterol chloroformate was dissolved in 5 mL of DCM and added dropwise to the mixture, and reacted in an ice bath at 0°C for 12 h. After the reaction was completed, DCM was removed by vacuum distillation at 33°C. The remaining product was transferred to a beaker, and ether was added thereto to wash away excess DCM, Chol and TEA. After drying, a PC sample was obtained and stored at -20°C.
[0068] Preparation of amphiphilic micelle dispersion: PC raw material was added into Tris-HCl buffer (50 mM, pH=8.5) at a concentration of 7.5 mg / mL.
[0069] (2) Preparation of dopamine-modified heparin (HPD): At 25°C and nitrogen, 1 g of heparin was dissolved in 100 mL of MES buffer (50 mM, pH = 5.5). The MES buffer was prepared by dissolving MES in deionized water, and the pH was adjusted to 5.5 using 5 M sodium hydroxide. After dissolution, 500 mg of EDC and 350 mg of NHS were added thereto, and the reaction was allowed to proceed for 30 min to activate the carboxyl group. Thereafter, 500 mg of dopamine was added under light-proof conditions, and the reaction was allowed to proceed for 24 h, during which the pH was maintained at 5 to 6. The HPD sample was obtained by dialysis using deionized water at pH = 5 (molecular weight cutoff of 3500 Da) for 3 days, with the water changed 3 times a day, and freeze-dried. The deionized water at pH = 5 was obtained by adjusting the pH using MES.
[0070] Preparation of solution A: The freeze-dried HPD raw material was added into Tris-HCl buffer (50 mM, pH=8.5) at a ratio of 10 wt.%, and heated at 50° C. for 3 h to dissolve, thereby obtaining solution A.
[0071] (3) Preparation of 3-carboxy-4-fluorophenylboronic acid modified chitosan oligosaccharide (CFP): 777 mg of 3-carboxy-4-fluorophenylboronic acid was dissolved in 130 mL of DM solvent (V (DMSO:MES)=1:1). After it is dissolved, 897 mg EDC and 539 mg NHS are added thereto, and the reaction is carried out for 30 min to activate the carboxyl group. Then, 1 g chitosan oligosaccharide is added thereto, and the pH value of the solution is maintained at 5-6. The reaction is carried out for 24 h. The CFP sample is dialyzed with deionized water (molecular weight cut-off is 1000 Da) for 3 days, the water is changed 3 times a day, and freeze-dried to obtain the CFP sample.
[0072] Preparation of solution B: Add the freeze-dried CFP raw material at a ratio of 20 wt.% to the amphiphilic micelle dispersion prepared in step (1), heat and dissolve at 50°C for 3 h to obtain solution B.
[0073] (4) Preparation of bio-based wet adhesion hydrogel: Solution A in step (2) and solution B in step (3) were fully stirred for 0.5 min and then cross-linked to obtain HPCF7.5C hydrogel.
[0074] Embodiment 6:
[0075] A method for preparing a bio-based wet adhesion hydrogel of the present invention comprises the following steps:
[0076] (1) Preparation of amphiphilic polymer cholesterol polyethyleneimine (PC): 1.85 g of branched polyethyleneimine was dissolved in 20 mL of DCM, stirred evenly in an ice bath, and after fully dissolved, 186 μL of TEA was added thereto. Then, 0.2 g of cholesterol chloroformate was dissolved in 5 mL of DCM and added dropwise to the mixture, and reacted in an ice bath at 0°C for 12 h. After the reaction was completed, DCM was removed by vacuum distillation at 33°C. The remaining product was transferred to a beaker, and ether was added thereto to wash away excess DCM, Chol and TEA. After drying, a PC sample was obtained and stored at -20°C.
[0077] Preparation of amphiphilic micelle dispersion: PC raw material was added into Tris-HCl buffer (50 mM, pH=8.5) at a concentration of 7.5 mg / mL.
[0078] (2) Preparation of dopamine-modified chondroitin sulfate (CSD): At 25°C and nitrogen, 1 g of chondroitin sulfate was dissolved in 100 mL of MES buffer (50 mM, pH = 5.5). The MES buffer was prepared by dissolving MES in deionized water, and the pH was adjusted to 5.5 using 5 M sodium hydroxide. After dissolution, 500 mg of EDC and 350 mg of NHS were added thereto, and the reaction was allowed to proceed for 30 min to activate the carboxyl group. Thereafter, 500 mg of dopamine was added under light-proof conditions, and the reaction was allowed to proceed for 24 h, during which the pH was maintained at 5 to 6. The CSD sample was dialyzed using deionized water at pH = 5 (molecular weight cut-off of 3500 Da) for 3 days, with the water changed 3 times a day, and freeze-dried. The deionized water at pH = 5 was obtained by adjusting the pH using MES.
[0079] Preparation of solution A: The freeze-dried CSD raw material was added into Tris-HCl buffer (50 mM, pH=8.5) at a ratio of 6 wt.%, and heated to dissolve at 40° C. for 2 h to obtain solution A.
[0080] (3) Preparation of ε-polylysine hydrochloride (EFP) modified with 3-carboxy-4-fluorophenylboronic acid: 777 mg of 3-carboxy-4-fluorophenylboronic acid was dissolved in 130 mL of DM solvent (V (DMSO:MES) =1:1). After it is dissolved, 897 mg EDC and 539 mg NHS are added thereto, and the reaction is carried out for 30 min to activate the carboxyl group. Then, 1 g ε-polylysine hydrochloride is added thereto, and the pH value of the solution is maintained at 5-6. The reaction is carried out for 24 h. The EP sample is dialyzed with deionized water (molecular weight cut-off is 1000 Da) for 3 days, the water is changed 3 times a day, and the EP sample is obtained by freeze drying.
[0081] Preparation of solution B: Add the freeze-dried EFP raw material at a ratio of 20 wt.% to the amphiphilic micelle dispersion prepared in step (1), heat and dissolve at 40°C for 2 h to obtain solution B.
[0082] (4) Preparation of bio-based wet adhesion hydrogel: Solution A in step (2) and solution B in step (3) were fully stirred for 1 min and then cross-linked to obtain CSEF7.5C hydrogel.
[0083] It should be noted that MES is the abbreviation of morpholineethanesulfonic acid; EDC is the abbreviation of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride; NHS is the abbreviation of N-hydroxysuccinimide; DMSO is the abbreviation of dimethyl sulfoxide; DCM is the abbreviation of dichloromethane; and TEA is the abbreviation of triethylamine.
[0084] The performance test of the hydrogel prepared in Example 1 showed that its lap-shear adhesion strength to pork tissue under water was as follows: Figure 1 As shown in the figure, it can be seen that with the increase of PC content, the adhesion strength of the hydrogel gradually increases. When the PC concentration exceeds a certain range, the cross-linking density of the polymer network is too high, which restricts the movement of the chain and reduces the adhesion strength. When the PC content is 7.5 mg / mL, the prepared HE7.5C hydrogel has the optimal adhesion strength.
[0085] The hydrogel adhesion effect was then tested using different wet tissue specimens. The adhesion effects on the surface of the heart, lungs, spleen, and kidneys were as follows: Figure 2 shown.
[0086] The swelling ratio of the hydrogel prepared by the present invention was compared with that of the hydrogel prepared by free radical polymerization. Figure 3As shown, it can be seen that the HE7.5C prepared in the present invention has a low swelling rate and exhibits excellent anti-swelling performance.
[0087] Figure 4 The rheological properties of the hydrogel prepared in the present invention are shown in Table 1. The formation kinetics of the hydrogel were evaluated by evaluating G′ (storage modulus) and G″ (loss modulus). Figure 4 As shown in (a), G′ exceeds G″ and exhibits frequency-dependent behavior, indicating the formation of an elastic network. Figure 4 (b) The ideal elastic properties of the hydrogel were observed by strain sweep, where G′ was lower than G″ at a strain of about 500%, indicating that the hydrogel decomposed into a quasi-liquid state. Figure 4 (c) The self-healing ability was evaluated by applying two cycles of strain between 1% and 600%. Under low shear strain (1%), the hydrogel maintained a complete network. However, under high shear strain (600%), G″ exceeded G′, indicating that the hydrogel network was destroyed. When low shear strain (1%) was applied again, G′ recovered and exceeded G″, and the hydrogel network was quickly rebuilt, indicating that the hydrogel has excellent self-healing properties.
[0088] The above description is not limited to any specific embodiment, nor does it represent the best embodiment. General substitutions known to those skilled in the art are also included in the scope of protection of the present invention.
Claims
1. A method for preparing a bio-based wet adhesion hydrogel, characterized in that: The following steps are involved: Step 1: grafting cholesterol chloroformate onto the main chain of polyethyleneimine through an acyl chloride reaction to obtain an amphiphilic polymer cholesterol polyethyleneimine; adding the amphiphilic polymer into an alkaline solution to prepare an amphiphilic micelle dispersion; Step 2: Grafting dopamine onto the main chain of anionic polysaccharide through amide reaction to obtain dopamine-modified anionic polysaccharide; adding the dopamine-modified anionic polysaccharide into an alkaline solution, heating and dissolving to obtain solution A; Step 3: Grafting dihydroxyphenylborane groups onto the main chain of the cationic polymer through an amide reaction to obtain a dihydroxyphenylborane-modified cationic polymer; adding the dihydroxyphenylborane-modified cationic polymer to the amphiphilic micelle dispersion prepared in step 1, heating and dissolving, to obtain a B solution; Step 4: The solution A in step 2 and the solution B in step 3 are mixed, stirred sufficiently, and then cross-linked to obtain a bio-based wet adhesion hydrogel.
2. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In the step 1, the concentration of the amphiphilic micelle dispersion is 0-15 mg / mL, and the alkaline solution is a solution with a pH value greater than 7.
3. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In the step 2, the anionic polysaccharide is selected from any one of the following: hyaluronic acid, sodium alginate, fucoidan, gellan gum, heparin, and chondroitin sulfate.
4. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In the step 2, the content of dopamine-modified anionic polysaccharide in solution A is 2-10 wt.%.
5. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In step 2, the heating temperature is 30 to 60° C. and the heating time is 1 to 3 hours.
6. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In the step 3, the cationic polymer is selected from any one of the following: ε-polylysine hydrochloride, chitosan oligosaccharide; the substance containing dihydroxyphenylboryl is selected from any one of the following: 4-carboxyphenylboronic acid, 3-carboxy-4-fluorophenylboronic acid.
7. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In the step 3, the content of the dihydroxyphenylboryl-modified cationic polymer in the solution B is 20-50 wt.%.
8. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In step 3, the heating temperature is 30 to 60° C. and the heating time is 1 to 3 hours.
9. The method for preparing a bio-based wet adhesion hydrogel according to claim 1, characterized in that: In step 4, the stirring time is 0.5 to 3 minutes.
